About Kristin
Kristin Wall provides strategic legal counsel in all areas of intellectual property law, including patent, trademarks, industrial design and copyright matters. She has extensive experience advising the innovative pharmaceutical and medical device industry in a breadth of complex litigation and administrative proceedings under the Patent Act, Food and Drugs Act, Patented Medicines (Notice of Compliance) Regulations, Patented Medicines Regulations, Certificate of Supplementary Protection (CSP) Regulations and Food and Drug Regulations. Ms. Wall has acted in many of the first litigation proceedings started under Canada's CETA-reformed patent legislation, including as counsel in the first series of court challenges under the amended Patented Medicines (Notice of Compliance) Regulations and CSP Regulations to secure patent term restoration. She frequently advises clients on drug pricing, and litigated two pharmaceutical industry-wide court challenges to regulations and guidelines governing the Patented Medicine Prices Review Board (PMPRB). Ms. Wall's advisory work focusses on regulation that is most susceptible to litigation, including issues involving pricing, reimbursement, access to information, supply chain, licensing, Patent Register listings, data protection exclusivity, CSPs. Her in-depth understanding of how her clients are regulated enables Ms. Wall to risk manage, issue-spot and develop early litigation and market exclusivity strategies. Ms. Wall is a registered trademark agent and her trademark practice focuses on the registrability of trademarks, brand strategy and general trademark litigation. Her copyright practice focuses on copyright authorship and ownership disputes and providing opinions on licensing and enforcement. Ms. Wall has appeared at all levels of the Federal Court and before the Supreme Court of Canada. She is a frequent presenter and author, and is editor of the firm's Pharma in Brief bulletin.
Kristin Wall provides strategic legal counsel in all areas of intellectual property law, including patent, trademarks, industrial design and copyright matters. She has extensive experience advising the innovative pharmaceutical and medical device industry in a breadth of complex litigation and administrative proceedings under the Patent Act, Food and Drugs Act, Patented Medicines (Notice of Compliance) Regulations, Patented Medicines Regulations, Certificate of Supplementary Protection (CSP) Regulations and Food and Drug Regulations. Ms. Wall has acted in many of the first litigation proceedings started under Canada's CETA-reformed patent legislation, including as counsel in the first series of court challenges under the amended Patented Medicines (Notice of Compliance) Regulations and CSP Regulations to secure patent term restoration. She frequently advises clients on drug pricing, and litigated two pharmaceutical industry-wide court challenges to regulations and guidelines governing the Patented Medicine Prices Review Board (PMPRB). Ms. Wall's advisory work focusses on regulation that is most susceptible to litigation, including issues involving pricing, reimbursement, access to information, supply chain, licensing, Patent Register listings, data protection exclusivity, CSPs. Her in-depth understanding of how her clients are regulated enables Ms. Wall to risk manage, issue-spot and develop early litigation and market exclusivity strategies. Ms. Wall is a registered trademark agent and her trademark practice focuses on the registrability of trademarks, brand strategy and general trademark litigation. Her copyright practice focuses on copyright authorship and ownership disputes and providing opinions on licensing and enforcement. Ms. Wall has appeared at all levels of the Federal Court and before the Supreme Court of Canada. She is a frequent presenter and author, and is editor of the firm's Pharma in Brief bulletin.
